Results 181 to 190 of about 13,680 (210)
Some of the next articles are maybe not open access.
THERAPEUTIC STUDIES IN HYPERTHYROIDISM: METHIMAZOLE
The Journal of Clinical Endocrinology & Metabolism, 1952INTRODUCTION In the last few years many new agents have been presented to the clinician for the treatment of hyperthyroidism. A great deal of experience and the collected reports of many investigators are necessary before the final role of each of these substances can be definitely determined.
H H, STONE, D W, PETIT, P, STARR
openaire +2 more sources
Methimazole and Agranulocytosis — Clinical Study
Experimental and Clinical Endocrinology & Diabetes, 2009The paper deals with agranulocytosis as one of the side effects of methimazole. The analysis of 7 cases allows some conclusions in respect to prevention, early detection and treatment of this rare but serious complication.
U, Tuschy, J, Mühlan
openaire +2 more sources
[Methimazole versus methimazole and diphosphonates in hyperthyroid and osteoporotic patients].
Minerva endocrinologica, 2005It is well-know that hyperthyroidism is one of the key causes of secondary osteoporosis. High values of thyroid hormones increase the bone mineral turnover speed by promoting osteoclastic and osteoblastic activities. The aim of our study is to evaluate the increase of bone mineral density (BMD) in osteoporotic and hyperthyroid patients treated with ...
LUPOLI GA +9 more
openaire +2 more sources
Scandinavian Journal of Rheumatology, 1990
(1990). Methimazole and Arthritis. Scandinavian Journal of Rheumatology: Vol. 19, No. 5, pp. 385-385.
openaire +1 more source
(1990). Methimazole and Arthritis. Scandinavian Journal of Rheumatology: Vol. 19, No. 5, pp. 385-385.
openaire +1 more source
Methimazole Drug Allergy: A Possible Solution Using a “Methimazole Solution”
Endocrine Practice, 2021David S, Cooper, N Franklin, Adkinson
openaire +2 more sources